Processes that alter the sequence, structure, or number of deoxyribonucleic acids can cause disease but may also contribute to the spectrum of normal phenotypic variation and promote genome evolution of our species. In this issue of Cell, Liu et al. (2017) describe a DNA mutational process in which multiple DNA copy number variants are generated de novo (MdnCNVs) in four or more independent events, leading to a genomic disorder.
An important source of genome variation among individuals is copy number variation (CNV). CNV refers to a segment of DNA, 50 bases to several megabases in size, that is either lost or gained in one individual, but not another. It has been estimated that 4.8%-9.5% of the human genome shows CNV among healthy individuals (Zarrei et al., 2015) . However, CNVs can also cause a range of diseases, from neurological and developmental disorders to cancer and embryonic lethality. Multiple molecular mechanisms causing de novo CNVs have been identified, including DNA recombination-, replication-, and repairassociated processes (Carvalho and Lupski, 2016 ). De novo CNVs over 100 kb appear in 1.2% of meioses (Itsara et al., 2010) , but the occurrence of more than one de novo CNV is extremely rare. Liu et al. (2017) set out to identify individuals showing an excessive level of CNVs. Looking at the personal genome data obtained from clinical chromosomal microarray analysis, they observed multiple de novo CNVs in five out of 60,000 individuals. For two of these five, the authors then sequenced the complete genomes of both the individuals and their parents. In total, 34 de novo CNVs-five to ten dnCNVs per individual-were characterized. The analysis identified an MdnCNV signature characterized by multiple independent events involving different chromosomes of the same individual. These events result most often in DNA copy number gains (> 100kb), which appear either as tandem duplications (26 out of 34) or as more complex DNA rearrangements. The breakpoint junctions often reveal sequence ''microhomeology,'' a term the authors use to refer to a high but imperfect sequence identity between two short DNA sequences.
The excess of DNA gains versus losses (33:1) and the sequence composition of the breakpoints strongly suggested that the MdnCNV mutational process involves an erroneous DNA replicative mechanism. Interestingly, sequence analysis revealed that multiple breakpoints united maternal and paternal sequences, indicating that these rearrangements arose post-fertilization. Also, MdnCNVs within the same individual were found to be of both paternal and maternal genetic origin. Together, these observations strongly suggest that the MdnCNV process operates in the zygote or early in the preimplantation embryo, which is somewhat surprising given the fact that these CNVs are found in all cells: if the CNVs initially arise in only some embryonic cells, one might expect to find a mosaic pattern of CNV cells in the adult. However, the lack of mosaicism may reflect the fact that not all blastomeres of a cleavage-stage embryo necessarily contribute to the fetal cell lineage (Figure 1 ).
The observation of an MdnCNV mutator phenotype occurring during early embryogenesis is perhaps not surprising in light of the chromosomal instability (CIN) that has been observed during the first cell cycles of human life. Previous studies, employing single-cell genome analyses of all blastomeres from a human cleavage-stage embryo, produced by in vitro fertilization (IVF), have shown that up to 90% of embryos acquire numerical or structural chromosome anomalies (Vanneste et al., 2009) . Furthermore, the detection of compound maternalpaternal chromosomes in de novo unbalanced translocation carriers indicates that CIN processes also occur in the embryo in vivo (Robberecht et al., 2013) . The MdnCNV mutations may thus represent another manifestation of this phenomenon. Furthermore, it is conceivable that part of the singleton de novo CNVs also originate by a similar process.
It remains to be determined whether the MdnCNV mutator phenotype operates solely in preimplantation embryos or also during gametogenesis, whether it is a one-off event in one cell or rather a series of cumulative events in successive daughter cells, and how frequently it occurs. Single-cell genome sequencing of human gametes, zygotes, and cleavagestage embryos (together with control parental DNA) could shed light on these questions by revealing the lineal history of acquired CNVs. It may not be necessary to sequence 60,000 embryos, as the process may be more common. It is possible that embryonic cells with acquired numerical and/or structural chromosome anomalies are selected against (Greco et al., 2015) , only rarely contributing to live births. In that case, Liu et al. (2017) are only observing the five rare-term embryos that have passed the selection barrier. However, in that case, why have these abnormalities not been observed previously in the cells of the thousands of embryos that have already been biopsied for preimplantation genetic diagnostics (Vermeesch et al., 2016) ? It is plausible that the MdnCNV signature has been disregarded as a technical artifact of the DNA amplification required prior to sequencing or microarray analysis of the cell(s) (Gawad et al., 2016) . Furthermore, DNA gains in one cell without complementary DNA losses in sister blastomere(s) -as could be expected for a MdnCNV mutator phenotype-have previously been considered untrustworthy (Vanneste et al., 2009) . Integrating single-cell DNA copy number with structural variant profiling techniques could thus expose MdnCNVs in single cells and provide a more accurate picture of their distribution and frequency in gametes and embryonic cells.
The primary trigger for MdnCNV, and CIN in general, remains to be determined. In the patients analyzed by Liu et al. (2017) , blood samples taken at a later time point revealed no new CNVs, suggesting that the mutational process is transient in nature. Consistent with this possibility, the authors did not identify any mutations that could account for the MdnCNV mutator phenotype. Instead, the authors hypothesize that a mutation causing the mutator phenotype could be present in the maturing oocyte, but not passed on to the zygote during maternal meiosis. This hypothesis leads to an elegant model involving a simple on-off mechanism: until the 4-8 cell stage, human embryogenesis relies largely on maternal-rather than zygotic-transcripts and proteins. During this early phase, the mutant maternal transcript or protein, but not the gene, may transiently drive the MdnCNV mutator (the ''on'' phase). Once zygotic genome transcription is activated, a wild-type version of the protein is produced, turning the mutator off. Could this hypothesis be tested? Single-cell technologies are the answer here, as well. Genome-plustranscriptome sequencing of single cells The generation of multiple de novo copy number variants (MdnCNVs) may involve a stepwise accumulation of CNVs in gametogenesis and/or embryogenesis (i) or a single burst within the germline (not shown), the zygote (ii), or during the first cleavages with or without additional CIN-derived chromosome aberrations in the embryo (iii and iv, respectively). Inviable cells are selected out (''selection''). Thus, not every blastomere of a cleavage-stage embryo contributes to the fetal cell lineage, and as such, a mosaicism in the early embryo may still ultimately lead to a uniform genetic makeup in the adult (i and iii). Horizontal black bars represent the paternal and maternal genome with acquired de novo DNA gains (green). Cells of the same lineage are shown in the same colors. (Macaulay et al., 2017) may now be applied to embryos and could lead to the detection of MdnCNVs in the genome sequences of blastomeres prior to embryonic transcriptional activation. In parallel, the RNA-seq data of those same blastomeres can be scrutinized for the smoking gun, e.g., mutant maternal transcripts or aberrant levels of transcripts, perhaps corresponding to genes affecting DNA damage and repair pathways. It is also possible that mature oocytes or even individual blastomeres will show variations in their transcript profiles, causing some cells to be more prone to CIN than others. Liu et al. (2017) have identified a MdnCNV mutator phenotype. Characterizing the mechanisms that underpin this mutator phenotype-and CIN, in general-will likely advance our understanding of the origin of genomic disorders, as well as the contribution of similar processes to diseases such as cancer. Further study may also provide insight into genome evolution, as MdnCNV and CIN could provide a means for rapid adaptation of species to environmental changes.
